Stocks to buy today: Ultratech, DMart and Bajaj Auto on investors’ radar
Indian equity indices closed lower on Thursday as investors awaited inflation data. UltraTech Cement, Bajaj Auto, and DMart experienced declines. Analysts suggest cautious approaches for these stocks, recommending waiting for confirmed breakouts or reversals before investing.
F&O Ban List: PVR Inox, RBL Bank among 6 stocks under trade ban on Friday
Six stocks, including Granules India, Hindustan Copper, and PVR Inox, were under F&O trade ban on Friday due to high open interest exceeding market-wide position limits. Nifty and Sensex closed lower on Thursday, impacted by selling in bank, auto, and FMCG sectors.
PC Jeweller shares to trade ex-split on Monday. Last day to buy for eligibility
PC Jeweller announced a 1:10 stock split. The record date is December 16, 2024. Today is the last day to buy shares to be eligible. One Rs 10 share will become ten Re 1 shares. This move aims to increase accessibility for small investors and boost trading activity. This is the company’s first stock split.
RBI’s two-way operations to manage funds to sort out liquidity stress
A cut in cash reserve ratio (CRR) by 50 bps to 4%, effective from December 14 in two phases, will infuse Rs 1.16 lakh crore into the banking system.
Asian stocks drop ahead of next week’s Fed meeting
Japanese and Australian shares declined and equity futures for Hong Kong signaled losses after selling on Wall Street hit stocks and government bonds Thursday. The Nasdaq 100 slid 0.7% while the S&P 500 fell 0.5% as traders weighed higher-than-expected jobless claims against too hot producer price data.
Rupee plunges to record intraday, closing lows
“Demand from local importers continued to keep the rupee under pressure. There were some inflows, but they were all absorbed by the RBI. The central bank was seen protecting levels of 84.87 to 84.88 but RBI interventions did not change the direction of the pair,” said Anil Bhansali, head of treasury at Finrex Treasury Advisors.
Pharma, Capital Goods stocks new darlings of fund houses
India pharma companies’ progress in complex generics, stable US pricing and steady sales growth in India led to fund houses buying into stocks like Alembic Pharma, Divis Labs, Glenmark, Medplus, Orchid and Sanofi Consumer.
Bank deposits went up in line with credit growth in year to Nov
Indian banks saw a 10.6% rise in public deposits to ₹224.7 lakh crore between November 2023 and November 2024, matching the growth in credit. Both term and demand deposits achieved double-digit growth. This balanced growth follows regulatory concerns about potential overheating in retail credit, leading to a more sustainable credit-deposit ratio.
Bourses raise the bar for SME offers
The National Stock Exchange (NSE), the country’s largest bourse, is asking IPO-bound SMEs to have free cash for at least two out of the three years preceding their IPO and provide a utilisation certificate from the statutory auditor to ensure proper use of funds raised through the IPO, said a person with direct knowledge of […]
IGI offers long-term play for investors keen on niche biz
The company’s revenues grew at a CAGR of 32.3% from ₹365 crore in FY22 to ₹638 crore in FY24. Net profit rose at a CAGR of 37.6% to ₹325 crore in FY24.